CFTR and cystic fibrosis: Translate Bio is currently conducting a phase I/II first in human randomized placebo-controlled trial with multiple escalating doses to test the safety and tolerability of MRT5005 nanoparticles to deliver CFTR mRNA to the airways in CF adults (NCT03375047).